Doxorubicin cardiotoxicity and cardiac function improvement after stem cell therapy diagnosed by strain echocardiography

Journal of Cancer Science and Therapy

Volumn 5, Issue 2, 2013, Pages 052-057

  Oliveira, Maira S ^a   Melo, Marcos B ^a   Carvalho, Juliana L ^a   Melo, Isabela M ^a   Lavor, Mario S L ^a   Gomes, Dawidson A ^a   de Goes, Alfredo M ^a   Melo, Marilia M ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Cardiotoxicity; Echocardiography; Flavonoid; Stem cell therapy

Indexed keywords

CAMELLIA SINENSIS EXTRACT; DOXORUBICIN; ENHANCED GREEN FLUORESCENT PROTEIN; FLAVONOID; PLANT EXTRACT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOTOXICITY; CONTROLLED STUDY; CORE TEMPERATURE; DEATH; DIARRHEA; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; HEART ARRHYTHMIA; HEART LEFT VENTRICLE FAILURE; HEART VENTRICLE FUNCTION; HISTOPATHOLOGY; MALE; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; RAT; SIDE EFFECT; STRAIN ECHOCARDIOGRAPHY; T WAVE; VOMITING; WEIGHT REDUCTION;

EID: 84874220799     PISSN: None     EISSN: 19485956     Source Type: Journal    
DOI: 10.4172/1948-5956.1000184     Document Type: Article

References (40)

1. Butany J, Ahn E, Luk A (2009) Drug-related cardiac pathology. J Clin Pathol 62: 1074-1084.
2. Gianni L, Herman EH, Lipshultz SE, Minotti G, Sarvazyan N, et al. (2008) Anthracycline cardiotoxicity: from bench to bedside. J Clin Oncol 26: 3777-3784.
3. Alves de Souza RC, Camacho AA (2006) Neurohormonal, hemodynamic, and electrocardiographic evaluations of healthy dogs receiving long-term administration of doxorubicin. Am J Vet Res 67: 1319-1325.
4. Testore F, Milanese S, Ceste M, de Concilis E, Parello G, et al. (2008) Cardioprotective effect of dexrazoxane in patients with breast cancer treated with anthracyclines in adjuvant setting: a 10-year single institution experience. Am J Cardiovasc Drugs 8: 257-263.
5. Aapro M, Bernard-Marty C, Brain EG, Batist G, Erdkamp F, et al. (2011) Anthracycline cardiotoxicity in the elderly cancer patient: a SIOG expert position paper. Ann Oncol 22: 257-267.
6. Yao CX, Li WY, Zhang SF, Zhang SF, Zhang HF, et al. (2011) Effects of Doxorubicin and Fenofibrate on the activities of NADH oxidase and citrate synthase in mice. Basic Clin Pharmacol Toxicol 109: 452-456.
7. Tan X, Wang DB, Lu X, Wei H, Zhu R, et al. (2010) Doxorubicin induces apoptosis in H9c2 cardiomyocytes: role of overexpressed eukaryotic translation initiation factor 5A. Biol Pharm Bull 33: 1666-1672.
8. Zhang Y, Kang YM, Tian C, Zeng Y, Jia LX, et al. (2011) Overexpression of Nrdp1 in the heart exacerbates doxorubicin-induced cardiac dysfunction in mice. PLoS One 6: e21104.
9. Bast A, Haenen GR, Bruynzeel AM, Van der Vijgh WJ (2007) Protection by flavonoids against anthracycline cardiotoxicity: from chemistry to clinical trials. Cardiovasc Toxicol 7: 154-159.
10. Soucek P, Kondrova E, Hermanek J, Stopka P, Boumendjel A, et al. (2011) New model system for testing effects of flavonoids on doxorubicin-related formation of hydroxyl radicals. Anticancer Drugs 22: 176-184.
11. Chen Y, Liu W, Li W, Gao C (2010) Autologous bone marrow mesenchymal cell transplantation improves left ventricular function in a rabbit model of dilated cardiomyopathy. Exp Mol Pathol 88: 311-315.
12. Williams AR, Hare JM (2011) Mesenchymal stem cells: biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease. Circ Res 109: 923-940.
13. Triantafyllou KA, Karabinos E, Kalkandi H, Kranidis AI, Babalis D (2009) Clinical implications of the echocardiographic assessment of left ventricular long axis function. Clin Res Cardiol 98: 521-532.
14. Sahlen A, Winter R (2011) How should we measure global and regional left ventricular systolic function? J Echocardiogr 9: 41-50.
15. Motoki H, Nakatani S, Abe H, Kanzaki H, Kitakaze M (2010) Heterogeneous contraction of the left ventricle demonstrated by 2-dimensional strain imaging. J Echocardiogr 8: 33-39.
16. O'Brien PJ (2008) Cardiac troponin is the most effective translational safety biomarker for myocardial injury in cardiotoxicity. Toxicology 245: 206-218.
17. Salcedo EE, Moloo J, Quaife R, Wolfel E (2010) Imaging heart failure in 2010. Curr Cardiovasc Imaging Reports 3: 303-316.
18. Goda A, Nakao S, Tsujino T, Yuba M, Otsuka M, et al. (2011) Determinants of plasma brain natriuretic peptide levels in untreated hypertensive patients. J Echocardiogr 9: 103-108.
19. Piegari E, Di Salvo G, Castaldi B, Vitelli MR, Rodolico G, et al. (2008) Myocardial strain analysis in a doxorubicin-induced cardiomyopathy model. Ultrasound Med Biol 34: 370-378.
20. Migrino RQ, Aggarwal D, Konorev E, Brahmbhatt T, Bright M, et al. (2008) Early detection of doxorubicin cardiomyopathy using two-dimensional strain echocardiography. Ultrasound Med Biol 34: 208-214.
21. Zuk PA, Zhu M, Ashjian P, De Ugarte DA, Huang JI, et al. (2002) Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 13: 4279-4295.
22. Hazari MS, Haykal-Coates N, Winsett DW, Costa DL, Farraj AK (2009) Continuous electrocardiogram reveals differences in the short-term cardiotoxic response of Wistar-Kyoto and spontaneously hypertensive rats to doxorubicin. Toxicol Sci 110: 224-234.
23. Kenk M, Thackeray JT, Thorn SL, Dhami K, Chow BJ, et al. (2010) Alterations of pre-and postsynaptic noradrenergic signaling in a rat model of adriamycin-induced cardiotoxicity. J Nucl Cardiol 17: 254-263.
24. Basu A, Sanchez K, Leyva MJ, Wu M, Betts NM, et al. (2010) Green tea supplementation affects body weight, lipids, and lipid peroxidation in obese subjects with metabolic syndrome. J Am Coll Nutr 29: 31-40.
25. Penney D, Benjamin M, Dunham E (1974) Effect of carbon monoxide on cardiac weight as compared with altitude effects. J Appl Physiol 37: 80-84.
26. Enselberg CD, Simmons HG, Mintz AA (1950) The effects of potassium upon the heart, with special reference to the possibility of treatment of toxic arrhythmias due to digitalis. Am Heart J 39: 713-728.
27. Tassan-Mangina S, Codorean D, Metivier M, Costa B, Himberlin C, et al. (2006) Tissue Doppler imaging and conventional echocardiography after anthracycline treatment in adults: early and late alterations of left ventricular function during a prospective study. Eur J Echocardiogr 7: 141-146.
28. Bauer M, Cheng S, Jain M, Ngoy S, Theodoropoulos C, et al. (2011) Echocardiographic speckle-tracking based strain imaging for rapid cardiovascular phenotyping in mice. Circ Res 108: 908-916.
29. Chandran K, Aggarwal D, Migrino RQ, Joseph J, McAllister D, et al. (2009) Doxorubicin inactivates myocardial cytochrome c oxidase in rats: cardioprotection by Mito-Q. Biophys J 96: 1388-1398.
30. Xiang P, Deng HY, Li K, Huang GY, Chen Y, et al. (2009) Dexrazoxane protects against doxorubicin-induced cardiomyopathy: upregulation of Akt and Erk phosphorylation in a rat model. Canc Chemother Pharmacol 63: 343-349.
31. Wattanapitayakul SK, Chularojmontri L, Herunsalee A, Charuchongkolwongse S, Niumsakul S, et al. (2005) Screening of antioxidants from medicinal plants for cardioprotective effect against doxorubicin toxicity. Basic Clin Pharmacol Toxicol 96: 80-87.
32. Anjos Ferreira AL, Russell RM, Rocha N, Placido Ladeira MS, Favero Salvadori DM, et al. (2007) Effect of lycopene on doxorubicin-induced cardiotoxicity: an echocardiographic, histological and morphometrical assessment. Basic Clin Pharmacol Toxicol 101: 16-24.
33. Sacerdote P, Niada S, Franchi S, Arrigoni E, Rossi A, et al. (2012) Systemic administration of human Adipose-derived Stem Cells (hASCs) reverts nociceptive hypersensitivity in an experimental model of neuropathy. Stem Cells Dev.
34. Hahn JY, Cho HJ, Kang HJ, Kim TS, Kim MH, et al. (2008) Pre-treatment of mesenchymal stem cells with a combination of growth factors enhances gap junction formation, cytoprotective effect on cardiomyocytes, and therapeutic efficacy for myocardial infarction. J Am Coll Cardiol 51: 933-943.
35. Schlosser S, Dennler C, Schweizer R, Eberli D, Stein JV, et al. (2012) Paracrine effects of mesenchymal stem cells enhance vascular regeneration in ischemic murine skin. Microvasc Res 83: 267-275.
36. Satake K, Lou J, Lenke LG (2004) Migration of mesenchymal stem cells through cerebrospinal fluid into injured spinal cord tissue. Spine 29: 1971-1979.
37. Assis AC, Carvalho JL, Jacoby BA, Ferreira RL, Castanheira P, et al. (2010) Time-dependent migration of systemically delivered bone marrow mesenchymal stem cells to the infarcted heart. Cell Transplant 19: 219-230.
38. Hara M, Murakami T, Kobayashi E (2008) In vivo bioimaging using photogenic rats: fate of injected bone marrow-derived mesenchymal stromal cells. J Autoimmun 30: 163-171.
39. Cargnoni A, Di Marcello M, Campagnol M, Nassuato C, Albertini A, et al. (2009) Amniotic membrane patching promotes ischemic rat heart repair. Cell Transplant 18: 1147-1159.
40. Sant'Anna LB, Cargnoni A, Ressel L, Vanosi G, Parolini O (2011) Amniotic membrane application reduces liver fibrosis in a bile duct ligation rat model. Cell Transplant 20: 441-453.